Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva Generic Price-Fixing Securities Suit Gets Class Status (1)
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva Is On The Prowl And Its Investors Are Taking Notice | Mint
Teva Gets Generic Price-Fixing Securities Suits Consolidated
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
Teva stock drops after conspiracy allegations on hiking drug prices
Allergan becomes largest shareholder in Teva - Globes
Teva: Warren Buffett Messed Things Up For Short-Sellers - Bloomberg
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Watch How to Trade Teva Pharmaceutical - Bloomberg
Israel's Teva offering free drugs to settle U.S. opiods case - Business - Haaretz.com
Teva Pharmaceuticals (TEVA) Stock Gets Upgraded at HSBC - TheStreet
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva's Budding Blockbusters Lend Respite From Legal Concerns
Teva Agrees to Stop Selling Amgen Generic Following Patent Infringement Settlement | Ctech
Teva (TEVA), AbbVie (ABBV) to Pay $161.5 Million in West Virginia Opioid Case - Bloomberg
Teva, Allergan ready to pay $5B to settle thousands of opioid lawsuits (TEVA) | Seeking Alpha
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
The Difficulties of Cloning a CEO - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
